160 related articles for article (PubMed ID: 15814671)
1. Antinuclear antigen B cells that down-regulate surface B cell receptor during development to mature, follicular phenotype do not display features of anergy in vitro.
Liu X; Manser T
J Immunol; 2005 Apr; 174(8):4505-15. PubMed ID: 15814671
[TBL] [Abstract][Full Text] [Related]
2. Quantitatively reduced participation of anti-nuclear antigen B cells that down-regulate B cell receptor during primary development in the germinal center/memory B cell response to foreign antigen.
Alabyev B; Rahman ZS; Manser T
J Immunol; 2007 May; 178(9):5623-34. PubMed ID: 17442945
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen.
Swanson-Mungerson MA; Caldwell RG; Bultema R; Longnecker R
J Virol; 2005 Jun; 79(12):7355-62. PubMed ID: 15919890
[TBL] [Abstract][Full Text] [Related]
4. Receptor editing can lead to allelic inclusion and development of B cells that retain antibodies reacting with high avidity autoantigens.
Liu S; Velez MG; Humann J; Rowland S; Conrad FJ; Halverson R; Torres RM; Pelanda R
J Immunol; 2005 Oct; 175(8):5067-76. PubMed ID: 16210610
[TBL] [Abstract][Full Text] [Related]
5. Progressive surface B cell antigen receptor down-regulation accompanies efficient development of antinuclear antigen B cells to mature, follicular phenotype.
Heltemes-Harris L; Liu X; Manser T
J Immunol; 2004 Jan; 172(2):823-33. PubMed ID: 14707052
[TBL] [Abstract][Full Text] [Related]
6. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain.
Pewzner-Jung Y; Friedmann D; Sonoda E; Jung S; Rajewsky K; Eilat D
J Immunol; 1998 Nov; 161(9):4634-45. PubMed ID: 9794392
[TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin M and D antigen receptors are both capable of mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigen.
Brink R; Goodnow CC; Crosbie J; Adams E; Eris J; Mason DY; Hartley SB; Basten A
J Exp Med; 1992 Oct; 176(4):991-1005. PubMed ID: 1402669
[TBL] [Abstract][Full Text] [Related]
8. In vivo assessment of the relative contributions of deletion, anergy, and editing to B cell self-tolerance.
Hippen KL; Schram BR; Tze LE; Pape KA; Jenkins MK; Behrens TW
J Immunol; 2005 Jul; 175(2):909-16. PubMed ID: 16002689
[TBL] [Abstract][Full Text] [Related]
9. Tolerance through indifference: autoreactive B cells to the nuclear antigen La show no evidence of tolerance in a transgenic model.
Aplin BD; Keech CL; de Kauwe AL; Gordon TP; Cavill D; McCluskey J
J Immunol; 2003 Dec; 171(11):5890-900. PubMed ID: 14634099
[TBL] [Abstract][Full Text] [Related]
10. IL-4 promotes Stat6-dependent survival of autoreactive B cells in vivo without inducing autoantibody production.
Morris SC; Dragula NL; Finkelman FD
J Immunol; 2002 Aug; 169(4):1696-704. PubMed ID: 12165489
[TBL] [Abstract][Full Text] [Related]
11. Ig light chain receptor editing in anergic B cells.
Tze LE; Baness EA; Hippen KL; Behrens TW
J Immunol; 2000 Dec; 165(12):6796-802. PubMed ID: 11120801
[TBL] [Abstract][Full Text] [Related]
12. Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells.
Ho WY; Cooke MP; Goodnow CC; Davis MM
J Exp Med; 1994 May; 179(5):1539-49. PubMed ID: 7909325
[TBL] [Abstract][Full Text] [Related]
13. Development of myelin oligodendrocyte glycoprotein autoreactive transgenic B lymphocytes: receptor editing in vivo after encounter of a self-antigen distinct from myelin oligodendrocyte glycoprotein.
Litzenburger T; Blüthmann H; Morales P; Pham-Dinh D; Dautigny A; Wekerle H; Iglesias A
J Immunol; 2000 Nov; 165(9):5360-6. PubMed ID: 11046072
[TBL] [Abstract][Full Text] [Related]
14. Incomplete activation of CD4 T cells by antigen-presenting transitional immature B cells: implications for peripheral B and T cell responsiveness.
Chung JB; Wells AD; Adler S; Jacob A; Turka LA; Monroe JG
J Immunol; 2003 Aug; 171(4):1758-67. PubMed ID: 12902475
[TBL] [Abstract][Full Text] [Related]
15. Virus-like display of a neo-self antigen reverses B cell anergy in a B cell receptor transgenic mouse model.
Chackerian B; Durfee MR; Schiller JT
J Immunol; 2008 May; 180(9):5816-25. PubMed ID: 18424700
[TBL] [Abstract][Full Text] [Related]
16. Peripheral tolerance to a nuclear autoantigen: dendritic cells expressing a nuclear autoantigen lead to persistent anergic state of CD4+ autoreactive T cells after proliferation.
Kawahata K; Misaki Y; Yamauchi M; Tsunekawa S; Setoguchi K; Miyazaki J; Yamamoto K
J Immunol; 2002 Feb; 168(3):1103-12. PubMed ID: 11801644
[TBL] [Abstract][Full Text] [Related]
17. Ig allotypic inclusion does not prevent B cell development or response.
Velez MG; Kane M; Liu S; Gauld SB; Cambier JC; Torres RM; Pelanda R
J Immunol; 2007 Jul; 179(2):1049-57. PubMed ID: 17617597
[TBL] [Abstract][Full Text] [Related]
18. Expression of a V region-less B cell receptor confers a tolerance-like phenotype on transgenic B cells.
Corcos D; Grandien A; Vazquez A; Dunda O; Lorès P; Bucchini D
J Immunol; 2001 Mar; 166(5):3083-9. PubMed ID: 11207259
[TBL] [Abstract][Full Text] [Related]
19. Transmodulation of BCR signaling by transduction-incompetent antigen receptors: implications for impaired signaling in anergic B cells.
Vilen BJ; Burke KM; Sleater M; Cambier JC
J Immunol; 2002 May; 168(9):4344-51. PubMed ID: 11970976
[TBL] [Abstract][Full Text] [Related]
20. Recently activated naive CD4 T cells can help resting B cells, and can produce sufficient autocrine IL-4 to drive differentiation to secretion of T helper 2-type cytokines.
Croft M; Swain SL
J Immunol; 1995 May; 154(9):4269-82. PubMed ID: 7536767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
